Eyebright Accounts Payable vs Net Invested Capital Analysis

688050 Stock   90.61  1.90  2.05%   
Eyebright Medical financial indicator trend analysis is much more than just examining Eyebright Medical latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Eyebright Medical is a good investment. Please check the relationship between Eyebright Medical Accounts Payable and its Net Invested Capital accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Eyebright Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Accounts Payable vs Net Invested Capital

Accounts Payable vs Net Invested Capital Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Eyebright Medical Accounts Payable account and Net Invested Capital. At this time, the significance of the direction appears to have strong relationship.
The correlation between Eyebright Medical's Accounts Payable and Net Invested Capital is 0.79. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Net Invested Capital in the same time period over historical financial statements of Eyebright Medical Technology, assuming nothing else is changed. The correlation between historical values of Eyebright Medical's Accounts Payable and Net Invested Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Eyebright Medical Technology are associated (or correlated) with its Net Invested Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Invested Capital has no effect on the direction of Accounts Payable i.e., Eyebright Medical's Accounts Payable and Net Invested Capital go up and down completely randomly.

Correlation Coefficient

0.79
Relationship DirectionPositive 
Relationship StrengthSignificant

Accounts Payable

An accounting item on the balance sheet that represents Eyebright Medical obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Eyebright Medical are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Net Invested Capital

The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.
Most indicators from Eyebright Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Eyebright Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Eyebright Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
The current year's Selling General Administrative is expected to grow to about 226.9 M, whereas Tax Provision is forecasted to decline to about 25.8 M.
 2021 2022 2023 2024 (projected)
Interest Expense736.9K2.0M9.8M10.3M
Depreciation And Amortization42.0M58.7M67.5M70.9M

Eyebright Medical fundamental ratios Correlations

0.960.320.930.910.96-0.610.960.870.860.970.740.990.840.920.940.250.880.930.87-0.350.960.910.340.80.96
0.960.460.860.920.88-0.690.890.760.890.890.750.950.770.850.820.370.90.860.9-0.310.880.890.370.720.96
0.320.460.00.560.11-0.580.14-0.150.530.120.590.320.110.1-0.020.570.590.050.65-0.20.080.50.61-0.050.44
0.930.860.00.740.99-0.350.980.980.680.990.580.920.850.980.970.010.681.00.65-0.280.980.740.170.860.87
0.910.920.560.740.8-0.740.80.640.960.810.820.90.840.740.760.430.990.740.97-0.350.810.990.450.740.96
0.960.880.110.990.8-0.41.00.960.721.00.660.950.850.980.970.040.740.990.71-0.310.990.790.260.860.9
-0.61-0.69-0.58-0.35-0.74-0.4-0.39-0.23-0.87-0.41-0.43-0.6-0.4-0.28-0.43-0.74-0.8-0.32-0.860.38-0.48-0.78-0.13-0.26-0.62
0.960.890.140.980.81.0-0.390.960.721.00.720.960.850.980.960.00.750.990.71-0.330.980.790.340.860.91
0.870.76-0.150.980.640.96-0.230.960.570.960.530.860.820.950.96-0.140.580.970.53-0.270.950.640.140.870.79
0.860.890.530.680.960.72-0.870.720.570.730.660.840.780.650.710.560.970.670.97-0.40.770.970.250.660.91
0.970.890.120.990.811.0-0.411.00.960.730.680.960.850.980.970.040.750.990.72-0.320.990.80.290.850.91
0.740.750.590.580.820.66-0.430.720.530.660.680.810.640.640.590.020.780.610.76-0.30.630.760.860.620.81
0.990.950.320.920.90.95-0.60.960.860.840.960.810.820.90.930.160.870.910.85-0.380.950.890.440.80.96
0.840.770.110.850.840.85-0.40.850.820.780.850.640.820.830.840.090.80.840.71-0.320.850.840.20.970.89
0.920.850.10.980.740.98-0.280.980.950.650.980.640.90.830.93-0.020.680.990.64-0.280.950.720.270.840.87
0.940.82-0.020.970.760.97-0.430.960.960.710.970.590.930.840.930.020.720.950.68-0.290.990.780.170.850.84
0.250.370.570.010.430.04-0.740.0-0.140.560.040.020.160.09-0.020.020.510.00.6-0.030.080.48-0.17-0.10.29
0.880.90.590.680.990.74-0.80.750.580.970.750.780.870.80.680.720.510.690.99-0.340.760.990.410.690.93
0.930.860.051.00.740.99-0.320.990.970.670.990.610.910.840.990.950.00.690.65-0.280.970.730.220.860.87
0.870.90.650.650.970.71-0.860.710.530.970.720.760.850.710.640.680.60.990.65-0.340.730.970.410.60.91
-0.35-0.31-0.2-0.28-0.35-0.310.38-0.33-0.27-0.4-0.32-0.3-0.38-0.32-0.28-0.29-0.03-0.34-0.28-0.34-0.33-0.33-0.15-0.26-0.37
0.960.880.080.980.810.99-0.480.980.950.770.990.630.950.850.950.990.080.760.970.73-0.330.810.210.840.89
0.910.890.50.740.990.79-0.780.790.640.970.80.760.890.840.720.780.480.990.730.97-0.330.810.370.740.94
0.340.370.610.170.450.26-0.130.340.140.250.290.860.440.20.270.17-0.170.410.220.41-0.150.210.370.220.42
0.80.72-0.050.860.740.86-0.260.860.870.660.850.620.80.970.840.85-0.10.690.860.6-0.260.840.740.220.83
0.960.960.440.870.960.9-0.620.910.790.910.910.810.960.890.870.840.290.930.870.91-0.370.890.940.420.83
Click cells to compare fundamentals

Eyebright Medical Account Relationship Matchups

Eyebright Medical fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets685.8M1.6B2.0B2.2B3.1B3.2B
Short Long Term Debt Total7.7M894.5K154.8M162.8M187.2M196.6M
Other Current Liab21.9M74.9M133.9M133.9M137.3K130.4K
Total Current Liabilities23.1M77.1M139.4M147.7M377.8M396.7M
Total Stockholder Equity617.6M1.5B1.7B1.9B2.1B1.2B
Property Plant And Equipment Net183.1M267.1M558.7M674.2M1.3B1.3B
Net Debt(195.4M)(536.8M)(318.0M)(192.1M)(172.9M)(181.5M)
Retained Earnings2.5M90.0M213.5M391.4M647.2M679.5M
Accounts Payable280.9K2.2M5.6M13.9M49.0M51.5M
Cash196.3M536.8M472.9M354.9M536.7M308.0M
Non Current Assets Total351.3M492.4M928.9M1.2B2.0B2.1B
Non Currrent Assets Other42.2M87.2M86.2M317.6M170.0M107.0M
Cash And Short Term Investments196.3M537.1M473.4M836.9M962.4M1.0B
Common Stock Shares Outstanding78.5M89.4M105.1M105.3M189.5M106.7M
Liabilities And Stockholders Equity685.8M1.6B2.0B2.2B2.6B2.7B
Non Current Liabilities Total15.1M13.8M168.0M176.6M328.1M344.5M
Inventory60.8M59.1M56.0M78.8M181.4M190.4M
Other Current Assets12.9M466.6M504.1M11.3M36.5M34.6M
Other Stockholder Equity536.2M1.3B1.4B1.4B1.6B845.9M
Total Liab38.3M90.9M307.5M324.3M705.9M741.1M
Total Current Assets334.5M1.1B1.1B1.1B1.0B718.5M
Intangible Assets100.6M112.9M127.8M140.3M252.2M264.8M
Common Stock78.8M78.8M105.1M105.2M121.0M93.5M

Currently Active Assets on Macroaxis

Other Information on Investing in Eyebright Stock

Balance Sheet is a snapshot of the financial position of Eyebright Medical at a specified time, usually calculated after every quarter, six months, or one year. Eyebright Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Eyebright Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Eyebright currently owns. An asset can also be divided into two categories, current and non-current.